ArticleBMJ open respiratory research2025

Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis.

Martin Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.